Cancer more likely to return for smokers

Share this content:
Patients with HPV-positive head and neck cancer who also smoke are likely to experience worse outcomes, according to a study published in Clinical Cancer Research (2010 Feb 15;16(4):1226-35).

Researchers from the University of Michigan Comprehensive Cancer Center conducted a study involving 124 patients with advanced oropharyngeal cancer, with the majority of participants having HPV DNA in their tumors. All 22 of the HPV-negative patients were tobacco users, and about two-thirds of the 102 HPV-positive patients were current or former tobacco users.

The study revealed that patients with HPV-positive tumors were 5 times more like to have their cancer return if they were current tobacco users.  Of the HPV-positive patients who had never used tobacco, 6% had a recurrence of their cancer. Researchers also reported that 19% of former tobacco users and 35% of current tobacco users had a recurrence.

“Because the effect of HPV is so strong in giving a very good prognostic picture, we were surprised to find that smoking remained a huge issue, and it actually affected the outcome in patients who smoked,” said senior study author Thomas Carey, PhD, professor of otolaryngology and pharmacology, and co-director of the head and neck oncology program at the U-M Comprehensive Cancer Center.

Researchers stated that the study suggests that current or former tobacco users may need more aggressive treatment regimens compared to patients who have never used tobacco.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs